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Abbreviations 
 
OLETF  Otsuka Long-Evans Tokushima Fatty 
AceCS  acetyl-CoA synthetase 
AMPK    AMP-activated protein kinase 
AID  auto-inhibitory domain 
CTD  carboxy-terminal domain 
CBS  cystathionine β-synthase 
LKB1  liver kinase B1  
CaMKKβ  calcium-calmodulin-dependent protein kinase kinase β 
CBM  carbohydrate-binding module 
KD  kinase domain 
GLUT4  glucose transporter type 4 
LETO    Long-Evans Tokushima Otsuka 
ACC     acetyl-CoA carboxylase 
FAS     fatty acid synthase 
LCACD   long-chain acyl-CoA dehydrogenase 
3KACT    3-ketoacyl-CoA thiolase 
MYO    myoglobin 
KLF15    kruppel-like factor 15 
PPARδ    Peroxisome proliferator-activated receptor delta 
PPARγ    Peroxisome proliferator-activated receptor gamma 
ChREBP   carbohydrate-responsive element binding protein 
MEF2    myocyte enhancer factor2 
DMEM    Dulbecco’s modified eagle medium 
FBS     fetal bovine serum 
PGC-1α   Peroxisome proliferator-activated receptor gamma coactivator 1-alpha 
AICAR   5-Aminoimidazole-4-carboxamide 1-beta-D-ribofuranoside 
araA     adenine 9-β-D-arabinofuranoside 
MADS     MCM1-agamous-deficiens-serum response factor 
MAPK     mitogen-activated protein kinase 
TGF-β    transforming growth factor β 
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Acetic acid is a short-chain fatty acid with 2 carbons of carboxyl group and it has a 
distinctive sour taste and pungent smell. Acetic acid is familiar food-composition that is 
the main component of vinegar. Vinegar contains about 4 to 8 % acetic acid [1,2]. The 
existence of vinegar was recorded in Babylonia at 5,000 BC [3] and it has been used for 
centuries as food preservative, taste enhancing and folk medicine. Vinegar is believed to 
have several health benefits. In human studies, it has shown an effect on reduced the 
glycemic index [4], reduced body weight, body fat mass and serum triglyceride levels [5], 
and prevent of hypertension [6]. The principle bioactive component of vinegar is acetic 
acid. Previously, it was reported that orally administered acetic acid exhibited to prevent 
hyperglycemic obesity with hyperinsulinemia and protect against fat accumulation in 
Otsuka Long-Evans Tokushima Fatty (OLETF) rats [7]. The acetic acid was absorbed by 
tissues and activated to acetyl-CoA with the concomitant formation of AMP by the 
catalytic activity of acetyl-CoA synthetase (AceCS) in the cytosol. The increase in AMP 
concentration led to an increase in the AMP/ATP ratio, following the phosphorylation of 
AMP-activated protein kinase (AMPK) [7]. AMPK is a heterotrimeric enzyme with α, β 
and γ subunits. The α-subunit contain a kinase domain at the N-terminal side, including 
the activation loop that has Thr-172, and an auto-inhibitory domain (AID) at the C-
terminal side. On the C-terminal side, there is α-subunit carboxy-terminal domain (α-
CTD) which binds to β-subunit via linker. The β-subunit is forming the core of the 
complex because of having β-subunit carboxy-terminal domain (β-CTD) that binds to the 
α-CTD of α-subunit and the amino terminus of γ-subunits. The γ-subunit has four tandem 
repeat of sequences that are named CBS1-CBS4 (CBS; cystathionine β-synthase). These 
act in pairs to form the binding sites for adenine nucleotides (AMP, ADP and ATP). The 
binding sites are termed site 1-site 4, correspond to the CBS1-CBS4 domain. Site 2 
appears to be empty and site 4 is always occupied by AMP. In the basis of state, sites 1 
and 3, that are regulatory sites, are preempted by ATP. Whereas phosphorylation of Thr-
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172 is promoted when AMP or ADP replace ATP at site 3. Furthermore, allosteric 
activation occurs by replacement ATP by AMP at site 1 (Fig 1) [8–13]. Activation of 
AMPK requires phosphorylation of Thr-172 in the α-subunit [14]. AMP binding to the γ-
subunit facilitates Thr-172 phosphorylation by upstream kinase, liver kinase B1 (LKB1) 
or calcium-calmodulin-dependent protein kinase kinase β (CaMKKβ), and induce 
significant structural change and protect dephosphorylating by protein phosphatases (Fig 
2) [8,11,15]. AMPK is a crucial cellular energy sensor and, can also influence metabolism 
and energy balance at the whole-body level. Therefore, activation of AMPK has important 
role in the prevention of obesity and diabetic, since activation of AMPK is involved in 
many physiological responses involving with anti-obesity and anti-diabetic action. 
 
 Fig 1. Schematic domain of the components of heterotrimer of AMPKs 
The catalytic α-subunits conventional serine/threonine kinase domains containing the threonine 
residue phosphorylated by upstream kinases. The β-subunit has carbohydrate-binding module 
(CBM) to which binds starch or glycogen. 
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Fig 2. Illustration of the AMPK activation by AMP. 
The AMPK complex consists of 3 different subunits: the α catalytic subunit that has a kinase 
domain (KD) and β and γ regulatory subunits. AMP binding to the γ-subunit causes a 
conformational change of the AMPK complex, which increases phosphorylation of the α-subunit 
at Thr-172, primarily by preventing dephosphorylation by protein phosphatases. 
 
Obesity and type 2 diabetes are increasing throughout the world due to change in 
lifestyles, dietary habits, or lack of exercise. The International Diabetes Federation 
Diabetes Atlas reported that there were 415 million people living with diabetes in the 
world at 2015. In addition, the number is expected to rise to 642 million by 2040. Also it 
has been reported to reach 7.2 million at 2015 in Japan [16]. One of the reason for 
continuous increase in diabetes is rapid aging in Japan, which is a serious social problem. 
There are type 1 and type 2 diabetes. Most of the diabetic patients worldwide are type 2 
diabetes. Type 2 diabetes is thought to be caused by obesity caused by lifestyle such as 
overeating and lack of exercise. It is reported that glucose metabolisms in liver, adipose 
tissues and brain of patients with type 2 diabetes are not different from healthy subjects, 
whereas it is reduced by about 35 to 40% in muscles of those patients [17]. Skeletal 
muscle mass decline with lack of exercise and aging, and loss of skeletal muscle directly 
leads to a decrease in energy metabolism and to an increase in the risk of obesity and 
diabetes. Skeletal muscle is the largest energy consuming organ and one of the important 
insulin response organ. Therefore, skeletal muscle is an important target in the study of 
obesity and diabetes.  
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The present author attempted to investigate the physiological function of acetic acid 
in skeletal muscle. The detail experimental data about the effect of acetic acid on 
laboratory animals shows in Chapter II. The mechanism of acetic acid by using cultured 
cell shows in Chapter III.  
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Chapter II 
 
Effects of Acetic acid on Lipid Metabolism in Muscles and 
Adipose Tissues of Type 2 Diabetic Otsuka Long-Evans 
Tokushima Fatty (OLETF) Rats 
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Obesity causes excess fat accumulation in adipose tissue, skeletal muscles and the 
liver. Especially, muscle lipid accumulation causes a predisposition to decrease insulin 
sensitivity [18–21]. We have reported that acetic acid had a profound anti-obese and anti-
diabetic function in animal models of obesity and type 2 diabetes [7]. Acetic acid is an 
endogenous metabolite of fatty acid β-oxidation in the liver mitochondria under starving 
conditions [22]. Acetic acid formed in the liver is excreted into the blood stream and is 
utilized as a biological fuel in the extrahepatic tissues under such conditions [22]. 
However, under fed conditions, orally administered acetic acid was immediately taken up 
from the intestine and excreted into the blood stream [7]. The acetic acid induced he 
phosphorylation of AMPK by increased in the AMP/ATP ratio [7]. AMPK acts as the key 
metabolic master switch, and regulates a number of enzymes involved in lipid 
homeostasis [23–28]. The ingested acetic acid activated AMPK by increasing the 
AMP/ATP ratio in the liver, and decreased the transcripts of the lipogenic genes [7]. 
Acetic acid administration protected the OLETF rats against obesity. It contributed to 
lowering the accumulation of abdominal fat and protected from the accumulation of lipid 
in the liver. An accumulation of excess lipid in the liver or skeletal muscle disturbs insulin 
signaling [29]. The marked reduction of lipid content in the adipose tissue and liver due 
to treatment with acetic acid contributed to improved glucose tolerance and insulin 
resistance as secondary effects in OLETF rats.   
The skeletal muscle is one of the most important insulin-responsive organs in the 
body [29,30], and it is possible that accumulation of locally derived fat metabolites in it 
is an important factor contributing to insulin resistance [29]. In the present study, we 
investigated the effects of acetic acid on the skeletal muscle and adipose tissues.  
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MATERIALS AND METHODS 
 
Acetic acid administration experiment 
Four-week-old male OLETF rats and Long-Evans Tokushima Otsuka (LETO) rats as 
a non-diabetic control were obtained from Otsuka Pharmaceutical (Tokushima, Japan) 
and fed a normal laboratory diet (CE2, Clea, Tokyo) for 1 week to stabilize the metabolic 
conditions. The rats were housed individually in an air-conditioned room at 
approximately 25°C with alternating 12 hr periods of light and dark (light, 8:00-20:00). 
All the animals were allowed free access to water and the appropriate diet. The OLETF 
rats were randomly assigned to two groups: water-injected and acetic acid-injected. The 
water-injected group was given distilled water at 5ml/kg of body weight, and the acetic 
acid-injected group was given 52.5 mg/kg of body weight (1% v/v) acetic acid of 5ml/kg 
of body weight) between 9:30 and 10:30 daily 5 day a week for 6 months. The initial body 
weights of the LETO, water-administered OLETF, and acetic acid-administered OLETF 
rats were 84 ± 26, 126 ± 10, and 125 ± 4 g respectively. Food consumption and body 
weight were recorded every day. At 32 weeks of age, the rats were anesthetized by 
intraperitoneal injection of Nembutal, (100 μl/100g of body weight), and muscles, white 
and brown adipose tissues were immediately isolated, weighed, frozen in liquid nitrogen, 
and stored at -80˚C for subsequent isolation of RNA. Part of the white adipose and brown 
adipose tissues of each rat was subjected to histochemical analysis. Tissue samples were 
taken 24 hr after injection of water or acetic acid. The care and use of the animals in this 
study followed the guidelines of Okayama Prefectural University and the laws and 
notifications of the Japanese government. 
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O2 consumption rates of OLETF rats administrated water or acetic acid and LETO 
rats. 
Oxygen consumption was measured with an O2/CO2 metabolism measuring system 
(model MK-5000, Muromachi Kikai, Tokyo). Each rat was in a sealed chamber with an 
air flow of 3.5 L/min for 24 hr at 25˚C with free access to water and the diet. The 
consumed oxygen concentration (VO2) was calculated. 
 
Preparation of cRNA probe for Northern blotting.   
The cDNA fragments for rat acetyl-CoA carboxylase (ACC), fatty acid synthase 
(FAS), long-chain acyl-CoA dehydrogenase (LCACD), 3-ketoacyl-CoA thiolase 
(3KACT), myoglobin (MYO), GLUT4, krupple-like factor (KLF15), peroxisome 
proliferator-activated receptor delta (PPARδ) , and peroxisome proliferator-activated 
receptor gamma (PPARγ) were obtained by polymerase chain reaction from a cDNA 
library for the rat heart (Takara Shuzo, Shiga, Japan) and rat brown adipose tissue mRNA 
that had been isolated with an mRNA isolation kit (Roche, Mannheim, Germany) from 
total RNA of rat brown adipose tissue. First-strand cDNA was prepared using Superscript 
II transcriptase primed with oligo-dT. The PCR primers used were as follows: ACC: 5' 
primer, 5'-GTTTGGCCTTTCACATGAGGTC-3', and 3' primer, 5' -
GTGGGGATACCTGCAGTTTGAG-3'.  FAS: 5' primer, 5' -
GACCCCTGTGGTGTTTGAGAAC-3', and 3' primer, 5' -
CTTGAGTGTCTCCCTCCAGCAT-3'.  LCACD: 5' primer, 5' -
CAAAAGGTCTGGGAGTGATTGG-3', and 3' primer, 5' -
GTCCAGACGTTTGGTTTCATGC-3'.  3KACT: 5' primer, 5' -
AGAAGACTGCGACAGATACGCC-3', and 3' primer, 5' -
TATTTTCCACCTCGACGCCTTA-3'.  PPARδ: 5' primer, 5'-
ACAACGCTATCCGCTTTGGAAG-3', and 3' primer, 5'-
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AAGAACTCATGGGTGACGAAGC-3'.  PPARγ: 5' primer, 5'-
GGTTGACACAGAGATGCCATTC-3', and 3' primer, 5'-
ACTTCTGAAACCGACAGTACTG-3'.  MYO: 5' primer, 5'-
GGAGTGGCAGATGGTGCTAAAC-3', and 3' primer, 5' -
GGAAGCCCAGCTCCTTGTACTT-3'.  GLUT4: 5' primer, 5'-
GCCCCACAGAAAGTGATTGAAC-3', and 3' primer, 5' -
CAGGTTCCGGATGATGTAGAGG-3'.  KLF15: 5' primer, 5'-
AAGCCTTCTGTTCCTGCTACAG-3', and 3' primer, 5' -
TGCTTCCTGCTTCACAGCAACA-3'.  The polymerase chain reaction was performed 
with Taq DNA polymerase (Takara Shuzo). Forty-one cycles of amplification were made 
following this program: 94°C, 1min; 66°C, 1 min; and 72°C, 2 min. The amplified 
products were subcloned into pGEM-T Easy vector (Promega, Madison, WI). These 
plasmid DNAs were used in DIG-RNA labeling by DIG labeling system (Roche, Schwiiz), 
and the cRNA probes were used as probes in Northern blotting. 
 
Northern blotting.   
Total RNA was extracted from each tissue using Isogen (Nippon Gene, Toyama, 
Japan). The RNA was dissolved in diethylpyrocarbonate-treated water and quantified by 
its absorbance at 260 nm. Total extracted RNA was denatured with formaldehyde and 
electrophoresed in 1% agarose gel containing formaldehyde; the amounts of loaded 
RNAs were checked by staining the 28 and 18 S rRNA bands with ethidium bromide.  
After capillary transfer to a nylon membrane (Roche, Schwiiz) and UV crosslinking, the 
membrane was hybridized overnight at 68˚C with DIG-labeled cRNA probes recognizing 
ACC, FAS, LCACD, 3KACT, PPARδ, PPARγ, MYO, GLUT4, and KLF15 respectively. 
The filter was washed twice with 2 × SSC and 0.1% SDS at room temperature, further 
washed twice with 0.1 × SSC and 0.1% SDS at 68˚C for 30 min, incubated with a blocking 
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solution and anti-DIG antibody-conjugated alkaline phosphatase for 30 min at room 
temperature, and then detected using CDP-Star (Roche, Schwiiz) by exposure to an X-
ray film. The amount of each transcript was quantified with an image analyzer (Gel Print 
2000i, Genomic Solutions, Tokyo) and was expressed as relative intensity. Each 
membrane was reprobed with β-actin to ensure that the changes observed did not reflect 
any unequal loading of the samples.   
 
Histological analysis of white adipose and brown adipose tissues.   
Small samples of tissues were fixed with a 20% formalin neutral buffered solution 
(Wako, Osaka, Japan) and embedded in paraffin. Sections (4.5 μm) were cut and stained 
with hematoxylin and eosin. Images were captured with a CCD camera (Olympus Optical, 
Tokyo) at a magnification of × 100 or 200.   
 
AMP, ADP, and ATP assays.  
The removed muscles were frozen quickly in liquid nitrogen, lyophilized, 
homogenized with ice-cold 0.5 N perchloric acid, neutralized, and centrifuged. The 
concentrations of AMP, ADP, and ATP in the various muscle extracts were determined by 
reverse-phase HPLC analysis. 
 
Western blotting   
The rat muscle samples were cut with scissors into small pieces, suspended in 20 mM 
potassium phosphate (pH 7.4), and homogenized with potter-Elvehjem equipment. The 
homogenate was centrifuged (20,000 × g, 10 min) to remove the tissue debris. An aliquot 
(30 μg of protein) of each muscle extract from the OLETF and LETO rats was applied to 
12% SDS acrylamide gel electrophoresis and then transferred to an Immobilon-P 
membrane (Millipore, Osaka, Japan). Immunoblot analysis was performed using the ECL 
Western blotting detection system (GE Healthcare, UK Ltd.).  Membrane sheets were 
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first incubated with the antibody against phosphopeptides based on the amino-acid 
sequence surrounding Thr-172 of the α-subunit of human AMPK (Cell Signaling, Beverly, 
MA) for 1 hr at room temperature, then washed several times and incubated with 
biotinylated goat anti-rabbit IgG, and subsequently with streptavidin-conjugated 
horseradish peroxidase, according to the protocol supplied by the manufacturer. We also 
determined the protein level of AMPKα using a specific antibody for the α subunit of 
AMPK. 
  
Statistical analysis   
The data values are presented as mean ± SE. Results were treated with one-way 
ANOVA followed by the Tukey-Kramer’s post hoc test for multiple comparisons (Figs. 
1, 2, 5), or analyzed by unpaired Student’s t test (Table 1). P values < 0.05 were considered 
to represent statistical significance. 
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RESULTS 
 
Effects of acetic acid on O2 uptake and energy metabolism      
At the age of 30 weeks, the average body weight was lower in the LETO and acetic 
acid-injected OLETF rats than in the water-injected OLETF rats (LETO, 535 ± 39 g; 
OLETF-acetic acid, 530 ± 35 g; OLETF-water, 679 ± 39 g). These results are similar to 
previous data. In order to determine whether acetic acid administration affects the total 
body metabolic rate, oxygen consumption in whole animals was measured. The acetic 
acid-administered OLETF rats showed higher rates of oxygen consumption than the 
water-administered OLETF rats in the active state (Fig. 1).   
 
Fig 1. Effects of Acetate Administration on the Oxygen Consumption of OLETF Rats. 
Acetic acid (52.5 mg/kg of BW) was orally administered to OLETF rats for 6 months. Oxygen 
consumption was measured at 20 weeks of age. Resting and active periods were from 7:30 to 
19:30 and from 19:30 to 7:30 respectively. Each data value is expressed as the mean ± SE for 3-
4 rats. *p<0.05 as compared with the water-injected OLETF rats or LETO rats. Reprinted and 
revised by BBB 73(3): 570-576, 2009. 
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Effects of acetic acid on mRNA expression involved in lipid metabolism in the skeletal 
muscle 
     To determine the effects of acetic acid administration on energy metabolism in the 
skeletal muscles of abdominal and forelegs, mRNA levels associated with energy 
metabolism were measured by Northern blotting (Fig 2). The genes associated with fatty 
acid β-oxidation did not change between the water-administered and the acetic acid-
administered OLETF rats (Fig 2B), but, as compared to the water-administered OLETF 
rats, the acetic acid-administered rats were about 2 times higher in transcripts of the 
myoglobin and GLUT4 genes in the abdominal muscle (Fig 2A). The transcript of the 
KLF15 gene tended to increase in the abdominal muscle of the acetic acid-administered 
rats. As for the forelegs, in a similar way, the transcripts of the myoglobin, GLUT4, and 
KLF15 genes were stimulated by the injection of acetic acid (Fig 3). As for the lipolytic 
genes, the LCACD and 3KACT mRNA levels were not significantly different between 
the water- and acetic acid-administered OLETF rats (Fig 3). 
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Fig 2. Effects of Acetate Administration on mRNA Levels of the Genes Involved with Energy 
Metabolism in Abdominal Muscles of OLETF Rats. 
Experimental conditions were the same as in Fig. 2. Total RNA from abdominal muscle was 
isolated from OLETF rats administered water or acetate (52.5 mg/kg of BW) and from LETO rats 
at 32 weeks of age. Twenty-μg aliquots of total RNA were subjected to electrophoresis and 
transferred to nylon membranes. The membrane filters were hybridized with the indicated DIG-
labeled cRNA probes. Each lane represents a sample from an individual rat. Data values are 
expressed as mean ± SE for 3 rats. *p<0.05; **p<0.01 as compared with water-injected OLETF 
rats or LETO rats. Reprinted and revised by BBB 73(3): 570-576, 2009. 
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Fig 3. Effects of Acetate Administration on mRNA Levels of the Genes Involved in Energy 
Metabolism in the Forelegs of OLETF Rats. 
Experimental conditions were the same as in Fig 2. Reprinted and revised by BBB 73(3): 570-
576, 2009. 
 
Effects of acetic acid on the change in the AMP/ATP ratio and the phosphorylation of 
AMPK in abdominal muscle 
     We determined the adenine nucleotide concentration in perchloric acid extracts of 
the abdominal muscle after intragastric injection of 105 mg/kg of BW of acetic acid.  
The AMP content of the muscle increased about 3-fold 2 min after injection of the acetic 
acid (Table 1). An increase in the AMP/ATP ratio should induce phosphorylation of 
AMPK, following AMPK activation. Phosphorylated AMPK in the muscles of the water- 
and acetic acid-injected OLETF rats was determined by western blotting.  In the acetic 
acid-injected OLETF rats, the protein level of phosphorylated AMPK was higher than in 
the water-injected rats (Fig 4A). In a similar way, in the acetic acid-injected SD rats, 
phosphorylation of AMPK was seen 3 min after injection of acetic acid (Fig 4B). 
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Fig 4. Effects of Acetate Administration on the Phosphorylation of AMPK in the 
Abdominal Muscles of Rats. 
A; The phosphorylation of AMPK and the total protein level of AMPK are shown in abdominal 
muscles of the water- and the acetate-injected OLETF rats and the LETO rats at 32 weeks of age. 
Abdominal muscle was excised 24 hr after injection of water or acetate. B; The phosphorylation 
of AMPK and the total protein level of AMPK are shown in abdominal muscles of 10-week-old 
male SD rats (body weight, 350–450 g) administered acetic acid at concentrations of 52.5 mg/kg 
of BW. Abdominal muscle was excised at each time point indicated after the injection of 52.5 
mg/kg of BW of acetate into individual rats. Reprinted and revised by BBB 73(3): 570-576, 2009. 
 
Table 1. Stimulation of the AMP/ATP Ratio in Abdominal Muscle after Oral Administration 
of Acetate 
Time 
(min) 
ATP ADP AMP Total 
AMP/ATP 
μmol/ g 
0 24.1 ± 1.9 3.3 ± 0.1 0.14 ± 0.02 27.6 ± 2.0 0.006 ± 0.001 
0.7 26.2 ± 0.4 3.4 ± 1.1 0.18 ± 0.04 29.7 ± 0.9 0.007 ± 0.002 
1 25.3 ± 2.1 3.4 ± 0.3 0.16 ± 0.03 28.8 ± 2.3 0.006 ± 0.001 
2 24.6 ± 3.0   3.9 ± 0.1**  0.41 ± 0.18* 28.9 ± 2.9  0.017 ± 0.008* 
3 25.7 ± 2.4 3.6 ± 0.3 0.15 ± 0.03 29.5 ± 2.5 0.006 ± 0.001 
10 24.4 ± 2.5 4.8 ± 1.2 0.17 ± 0.07 29.3 ± 3.1 0.007 ± 0.002 
The effects are shown of an acetate injection on the adenine nucleotide content and the AMP/ATP 
ratio in abdominal muscle. Acetate at concentration of 10.5 mg/kg of BW was orally injected into 
10-week-old male SD rats (body weight, 350–450 g; n=5-7 for each point). The abdominal muscle 
was excised at each time point indicated after the injection of 10.5 mg/kg of BW of acetic acid 
into an individual rat, then frozen and lyophilized, and the nucleotides were extracted. Each data 
value is expressed as the mean ± SE for 5-7 rats. *p<0.05, **p<0.01, compared with the 0 min 
point for the control rats. 
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Effects of acetic acid on the mRNA expression involved in lipid metabolism in white 
adipose and brown adipose tissues 
To determine the effects of acetic acid administration on fatty acid metabolism in 
adipose tissues, the mRNA levels associated with lipid metabolism were measured by 
Northern blotting (Fig 5). The genes associated with lipogenic enzymes did not change 
significantly between the water-administered and the acetic acid-administered OLETF 
rats (Fig 5A-2), but compared to the water-administered OLETF rats, the acetic acid-
administered ones tended to be enhanced in transcripts of the lipolytic genes, LCACD, 
3KACT, and PPARδ, higher by about 1.7, 1.6, and 1.7 times respectively (Fig 5A-1).  
Also, in brown adipose tissue, the transcripts of the LCACD, 3KACT, and PPARδ genes 
increased significantly (Fig 5B). 
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Fig 5. Effects of Acetate Administration on mRNA Levels of Lipolytic and Lipogenic 
Genes in the White Adipose (A) and Brown Adipose (B) Tissues of OLETF Rats. 
The experimental conditions were the same as in Fig 2, except that 10 μg aliquots of total RNA 
were subjected to electrophoresis. Reprinted and revised by BBB 73(3): 570-576, 2009. 
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Effects of acetic acid on lipid accumulation in white adipose and brown adipose 
tissues.   
Histological analysis indicated that the water-administered OLETF rats accumulated 
large-size droplets of lipid, although the acetic acid-administered OLETF rats showed 
smaller lipid droplets than the water-administered OLETF rats (Fig 6A). In a similar way, 
lipid droplets of a smaller size were observed in brown adipose tissue in acetic acid-
administered OLETF rats than the water-administered OLETF rats (Fig 6B). 
 
Fig 6. Histological Sections of White Adipose (A) and Brown Adipose (B) Tissues from 
LETO, Water-Administered OLETF, and 52.5 mg/kg of BW of Acetic Acid-Administered 
OLETF Rats.  
A; White adipose tissue (×100 magnification). B; Brown adipose tissue (×200 magnification). 
Sections were cut and stained with hematoxylin and eosin. Scale bars: A, 50 μm; B, 30 μm. 
Reprinted and revised by BBB 73(3): 570-576, 2009. 
 
 
 
 
 
 
 
 
 22 
 
DISCUSSION 
 
We have reported that acetic acid has an inhibitory effect on fatty acid synthesis in the 
liver and that it protects against lipid accumulation in adipose tissue and ameliorates 
obesity and diabetes in OLETF rats [7]. Orally administered acetic acid was immediately 
taken up from the intestine, absorbed by the liver, and this increased the AMP/ATP ratio. 
An increase in the AMP/ATP ratio stimulates the phosphorylation of AMPK, which 
regulates a number of enzymes involved in lipid homeostasis [23–28]. It is possible that 
acetic acid administration inactivated carbohydrate-responsive element binding protein 
(ChREBP), which is involved with the transcription of lipogenic genes via 
phosphorylation by AMPK in the liver [31–35]. Accumulation of excess lipid in the liver 
or skeletal muscle disturbs insulin signaling [29]. In this study, we focused on the effects 
of acetic acid in the skeletal muscle and adipose tissues. Acetic acid-administered OLETF 
rats showed increased oxygen consumption (Fig 1). The transcripts of myoglobin and 
GLUT4 increased significantly in the abdominal muscles of the OLETF rats administered 
acetic acid as compared with the OLETF rats administrated water. The ingested acetic 
acid activated AMPK by increasing the AMP/ATP ratio in abdominal muscle, as in the 
liver [7]. Acetic acid is converted to acetyl-CoA by a catalytic activity of acetyl-CoA 
synthetase in the cytosol. In our previous study, cytosolic type acetyl-CoA synthetase 
(AceCS1) was widely distributed in tissues containing skeletal muscle [36]. After acetic 
acid administration, the AMP content increased within 5 min of injection (Table 1), then 
AMPK was phosphorylated in the muscle by stimulation of a higher AMP/ATP ratio. 
Myoglobin is a cytosolic hemoprotein expressed selectively in cardiac and skeletal 
myocytes, where it functions to facilitate the diffusion of oxygen and to maintain 
mitochondrial respiration during muscle contraction [37]. In adult mammals, myoglobin 
expression is modulated by environmental stimuli, including chronic hypoxia and 
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endurance exercise training [38–41]. 
Myocyte enhancer factor2 (MEF2) is a transcription factor involved in skeletal 
muscle differentiation [42–44] and the regulation of myoglobin transcription [45–47]. 
Activation of MEF2 in skeletal muscle is regulated via parallel intracellular signaling 
pathways, including activation of AMPK [48]. It has been reported that MEF2 plays an 
important role in GLUT4 expression in skeletal muscle and that GLUT4 gene regulation 
is associated with AMPK activation [49,50]. Increases in the transcripts of the myoglobin 
and GLUT4 genes by acetic acid-treatment might be mediated by activation of MEF2 via 
AMPK activation. Transcription of the KLF15 gene tended to increase in the muscle with 
the administration of acetic acid. KLF15 has been reported to regulate transcription of the 
GLUT4 gene [51]. The physiological relationship between KLF15 and AMPK is now 
under investigation. 
The important role of AMPK is also shown by its association with adiponectin [52]. 
Adiponectin enhances insulin sensitivity and increases fatty-acid oxidation [53]. That 
function was shown to involve the activation of AMPK. The anti-diabetic drugs 
metformin and rosiglitazone can also activate AMPK, suggesting that AMPK plays an 
important role in the regulation of glucose and lipid metabolism [54,55]. 
On the other hand, acetic acid treatment had an effect in protecting against 
hypertrophy of the adipocytes. Lipid accumulation in brown adipose tissue was also 
inhibited by acetic acid treatment. In white adipose tissue, mRNA expression of fatty acid 
oxidizing enzymes was stimulated in the OLETF rats administered acetic acid. Activation 
of AMPK in rodent adipocytes was reported to lead to decreased lipogenic flux, decreased 
triglycerides synthesis, and an increase in fatty acid oxidation [56]. Activation of AMPK 
also had an inhibitory action on free fatty acid release [57] and decreased the availability 
of fatty acid in the plasma, and consequently it is beneficial in insulin-resistant states such 
as type 2 diabetes. Activation of AMPK in adipocytes has been found the lower 
 24 
 
expression and secretion of pro-inflammatory cytokines TNF-α and interleukin-6  
[58,59]. Whether acetic acid treatment activates AMPK in white and brown adipose 
tissues is now under investigation.   
The data obtained here prompt the suggestion that acetic acid has anti-obese and anti-
diabetic functions in the skeletal muscles and adipose tissues of an animal model of 
obesity and type 2 diabetes. 
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Chapter III 
 
Activation of AMP-activated Protein Kinase and Stimulation 
of Energy Metabolism by Acetic Acid in L6 Myotube Cells 
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AMPK, a heterotrimeric protein kinase, has been found to play a key role in 
regulation of whole-body energy balance by phosphorylating key metabolic enzymes in 
both biosynthetic and oxidative pathways [23–25,28,60–62]. AMPK is activated by a 
high AMP/ATP ratio in the cytosol, which occurs under heat shock, hypoxia, starvation, 
or physical exercise. AMPK activation results both from phosphorylation of Thr-172 on 
AMPK’s α-subunits via upstream AMPK kinase and by way of allosteric activation of 
phosphorylated AMPK by 5’-AMP [23–25,28,60–63]. Administered acetic acid 
increased AMP concentration, resulting in an increase of the AMP: ATP ratio, and led to 
the activation of AMPK in skeletal muscle [63]. This phenomenon is very similar to that 
induced by endurance exercise training. Furthermore, treatment with acetic acid increased 
the gene expression of myoglobin and GLUT4 in skeletal muscle of rats. GLUT4 is a 
well-known gene that is induced by activation of AMPK in skeletal muscle [25]. 
Expression of the myoglobin gene is modulated by environmental stimuli including 
chronic hypoxia or endurance exercise training [38–41]. Mutational analysis of the 
myoglobin promoter confirmed that A/T-rich MEF2-binding motifs were important in its 
gene regulation [64]. The human GLUT4 promoter is also regulated by the cooperative 
function of MEF2A [65], which is a transcription factor that plays a key role in skeletal 
muscle differentiation [42–44]. In differentiated myotubes, MEF2 is localized to the 
nucleus, indicating the importance of this transcription factor in specific skeletal muscle 
gene expression [46]. 
To investigate the function of acetic acid on AMPK activation and expression of 
genes such as myoglobin and GLUT4 that are involved with energy metabolism of 
skeletal muscle, we used L6 myotube cells and examined the effect of acetic acid. When 
added to the culture medium, acetic acid was rapidly taken up by L6 cells, and the 
phosphorylation of AMPK was stimulated. Transcripts and protein levels of myoglobin 
and GLUT4 were increased upon treatment with acetic acid. Furthermore, MEF2A levels 
 27 
 
in the nuclear fraction were increased. The uptake of glucose and fatty acid by cells were 
increased, while triglyceride accumulation was decreased upon treatment with acetic acid. 
These results indicate that treatment with acetic acid increases the expression of 
myoglobin and GLUT4 via the activation of AMPK and MEF2A, thus enhancing fatty 
acid metabolism and glucose uptake. 
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MATERIALS AND METHODS 
 
Materials 
Rat L6 myoblasts (JCRB9081) were purchased from JCRB cell bank (Osaka, Japan). 
Dulbecco’s modified eagle medium (DMEM), fetal bovine serum (FBS) and 0.02% 
EDTA were from MP Biomedical (CA, USA); penicillin, streptomycin, and 0.25% trypsin, 
from Invitrogen (CA, USA). Antibodies against AMPKα, phosphorylated AMPKα, ACC, 
phosphorylated ACC, and GLUT4 were purchased from Cell Signaling (MA, USA), 
antibodies against myoglobin, MEF2A, peroxisome proliferator-activated receptor 
gamma coactivator 1-alpha (PGC-1α) and Sp1 were from Santa Cruz Biotechnology (CA, 
USA), and α-tubulin antibody was from Wako Pure Chemical Industries Ltd. (Osaka, 
Japan). AMPK agonist 5-amino-4-imidazolecarboxamide-1-beta-D-ribofuranoside 
(AICAR) and AMPK inhibitor adenine 9-β-D-arabinofuranoside (araA) were purchased 
from Sigma-ALDRICH (MO, USA). AMPK inhibitor Compound C was purchased from 
Merck (DA, Germany) 
 
L6 cell culture  
 L6 myoblasts were grown in DMEM containing 10% (v/v) FBS, 100 units/ml 
penicillin, and 100 μg/ml streptomycin in 5% CO2 at 37 C. For myotube differentiation, 
the medium was changed to DMEM containing 2% (v/v) horse serum when myoblasts 
were 80% confluent. Myotubes were harvested 8-11 days after differentiation, and 
experimental procedures were initiated. 
 
Amount of acetic acid incorporated in cells 
Differentiated L6 myotube cells were treated with 0.5 mM (1 μmol/2ml) acetic acid 
for 0-30 min, and then the each conditioned medium that treated with acetic acid for each 
time period was collected and measured the concentration of acetic acid. The 
 29 
 
concentration of acetic acid remaining in the media was measured using the acetic acid 
UV-method kit (R-Biopharm AG, Darmstadt, Germany) according to the manufacturer’s 
instructions. The rates of acetic acid uptake were calculated by using the amount of acetic 
acid remaining in the medium, which averaged 473.1 μM (ca. 0.95 μmol/2ml), 394.0 μM 
(ca. 0.79 μmol/2ml), 390.0 μM (ca. 0.78 μmol/2ml) in 10sec, 2min, 30min of the 
treatment of acetic acid, respectively. 
 
Amount of glucose uptake into cells  
 Differentiated L6 myotube cells were treated with 0.5 mM acetic acid and 100 nM 
insulin for 24 and 48 hr in the medium that the glucose concentration was 25 mM (50 
μmol/2ml). Each conditioned medium that treated with acetic acid or insulin for 24 and 
48 hr was collected and measured the concentration of glucose. The concentration of 
glucose remaining in the media was measured using a commercial assay kit (Glucose CII-
Test Wako; Wako Pure Chemical Industries Ltd., Osaka, Japan). The amount of glucose 
uptake was calculated by using the amount of glucose remaining in the medium, which 
averaged 39 μmol and 32 μmol in 24 hr and 48 hr of the treatment of acetic acid, 
respectively, and 34 μmol and 20 μmol in 24 hr and 48 hr of the treatment of insulin, 
respectively. The amount of glucose remaining in the control medium averaged 44 μmol 
and 40 μmol in 24 hr and 48 hr, respectively. 
 
Amounts of fatty acid uptake and triglyceride accumulation 
 Differentiated L6 myotube cells were incubated with the medium containing 0.6 
μmol palmitic acid (300 μmol/L) for 24 and 48 hrs in the presence or absence of 0.5 mM 
acetic acid or 0.5 mM AICAR. After the incubation, mediums and cells were collected 
separately and the concentration of NEFA in the mediums and the concentration of TG in 
the cells were determined by using commercial assay kits (NEFA C-Test Wako and 
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Triglyceride E-Test Wako, respectively; Wako Pure Chemical Industries Ltd., Osaka, 
Japan). The amount of fatty acid uptake was calculated by using the concentration of fatty 
acid remaining in the medium, which averaged 0.263 μmol and 0.075 μmol in 24 hr and 
48 hr of the treatment of acetic acid, respectively, and 0.183 μmol and 0.149 μmol in 24 
hr and 48 hr of the treatment of AICAR, respectively. The amount of fatty acid remaining 
in the control medium averaged 0.316 μmol and 0.159 μmol in 24 hr and 48 hr, 
respectively. 
 
Nucleotide assay 
 Differentiated L6 myotube cells were treated with 0.5 mM acetic acid for 0-30 min 
and added to ice-cold 0.5 M perchloric acid, neutralized, and centrifuged. Concentrations 
of AMP, ADP, and ATP in the extracts of myotube cells were determined by reverse-phase 
HPLC analysis (SPD-10A, respectively; Shimazu, Kyoto, Japan) with an ODS column 
(HPLC PACKED COLUMN C18 CAPCELLPAK, respectively; Shimadzu Corporation, 
Kyoto, Japan). The mobile phase consisted of 100 mM phosphate buffer, pH 6.3 and 
0.89% methanol. Quantification was performed at λ＝259 nm. All chromatographic 
assays were carried out at room temperature with a flow of 1.0 ml/min. Adenosine 
nucleotides (ATP, ADP, and AMP) were identified and quantified based on the 
corresponding standard compounds. 
 
Nuclear extraction  
Myotubes were grown in 10-cm dishes, treated with acetic acid or AICAR as 
described above, and then washed immediately with ice-cold PBS. Hypotonic buffer (10 
mM HEPES pH 7.9, 1.5 mM MgCl2, 0.1 mM EDTA, 0.1% NP-40, 1 mM DTT, 1 mM 
PMSF, and protease inhibitors (Nacalai Tesque, Kyoto, Japan)) were added and the cells 
were collected. After homogenization, the extract was centrifuged for 5 min at 3,000 rpm 
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at 4 C, and the supernatant (cytoplasmic fraction) was collected. The nuclear pellet was 
resuspended in hypertonic buffer (20 mM HEPES pH 7.9, 1.5 mM MgCl2, 400 mM NaCl, 
0.1 mM EDTA, 0.1% NP-40, 10% glycerol, 1 mM DTT, 1 mM PMSF, and protease 
inhibitors) by pipetting. The suspension was incubated and shaken for 1 hr on ice. Then 
the supernatant (nuclear fraction) was collected by centrifugation at 15,000 rpm for 5 min. 
Protein concentration of the nuclear extract was determined by Bradford assay. 
 
AMPK activity 
To measure AMPK activity, AMPK was immunoprecipitated from cell extracts with 
specific antibodies against the α2-subunits bound to protein G agarose beads. The kinase 
activity of the immunoprecipitates was measured using SAMS peptide 
[HMRSAMSGLHLVKRR] and the Kinase-Glo Luminescent Kinase Assay kit (Promega, 
Madison, USA) according to the manufacturer’s instructions. 
 
Western blotting  
L6 myotube cells were washed with ice-cold PBS and lysed with RIPA buffer (1× 
TBS pH 7.4, 0.5% deoxycholic acid, 0.1% SDS, 1% NP-40, 1 mM PMSF, 1 mM Na3VO4, 
10 mM NaF, and protease inhibitors). Following centrifugation, supernatants were used 
for western blotting. Protein content of supernatants was determined by Bradford assay 
and an aliquot (15-30 μg of protein) of each extract from L6 cells was used for western 
blot to determine the contents of total AMPKα, phosphorylated Thr-172 AMPKα, total 
ACC, phosphorylated ACC, myoglobin, GLUT4, MEF2A, PGC-1α and α-tubulin. 
Samples were applied to 10-15% SDS-PAGE, and then proteins on the gel were 
transferred onto a polyvinylidene difluoride membrane (Merck, DA, Germany). The 
membranes were first incubated with primary antibodies overnight at 4C, washed three 
times with TBST, and they were incubated with HRP-conjugated secondary antibodies 
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for 60 min. For highly sensitive system, after the membranes were incubated with primary 
antibodies, they were incubated with biotin-conjugated secondary antibodies for 15-
30min, and they were incubated with HRP-conjugated streptavidin for 15min. After 
washing three times with TBST, the chemiluminescent reaction was performed for 5 min 
with ImmunoStar LD (Wako Pure Chemical Industries Ltd., Osaka, Japan), according to 
the protocol supplied by the manufacturer. Chemiluminescent signals were visualized and 
quantified with ImageQuant LAS-4000 and Multi Gauge V3.2 analyzing software 
(Fujifilm, Tokyo, Japan). 
 
Quantitative RT-PCR analysis 
Differentiated myotubes were incubated with 0.5 mM acetic acid and/or other 
reagents for the indicated time, and then the cells were washed three times with RNase 
free PBS and harvested for RNA extraction. Total RNA was isolated from L6 cells by 
using Sepasol RNA I super G (Nacalai Tesque, Kyoto, Japan), and RNase inhibitor 
(TOYOBO, Osaka, Japan) was added according to the manufacturer’s instructions. Total 
RNA concentration was measured and cDNA was prepared with PrimeScript RT Reagent 
Kit with gDNA Eraser (Takara Bio, Shiga, Japan) according to the manufacturer’s 
instructions. Real-time quantitative PCR analyses were performed using the StepOnePlus 
detection system (Applied Biosystems, CA, USA) with KAPA SYBR FAST qPCR Kits 
(Kapa Biosystems, Wilmington, MA) for quantification of specific mRNA content. Data 
were normalized to β-actin mRNA and expressed relative to untreated control cells. The 
oligonucleotide primers were as follows: rat β-actin  (actb) forward: 5’-
GGAGATTACTGCCCTGGCTCCTA-3’, reverse: 5’-GACTCATGTACTCCTGCTT 
GCTG-3’, rat GLUT4 (Slc2a4), forward: 5’-GGGCGATTTCTCCCACATAC-3’, 
reverse: 5’-CTCATGGGCCTAGCCAATG-3’, rat MEF2A  (mef2a), forward: 5’-
ATGAGAGGAACCGACAGGTG-3’, reverse: 5’-TATCCGAGTTCGTCCTGCTT-3’, 
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rat myoglobin (Mb), forward: 5’- CTAACAGCCGGCCTACACTC-3’, reverse: 5’-
CGTGCTTCTTCAGGTCCTCT-3’, PGC-1α (ppargc1a) forward: 5’-GACCCCA 
GAGTCACCAAATGA-3’, reverse:  5’-GGCCTGCAGTTCCAGAGAGT-3’. 
 
Immunofluorescence 
L6 cells were fixed with 4% formaldehyde solution, incubated with 0.1% Triton X-
100/PBS for 3 min, and blocked with 3% BSA/PBS for 10 min. Samples were incubated 
at room temperature for 1 hr with primary anti-MEF2A antibody (Santa Cruz 
Biotechnology) and anti-skeletal myosin antibody (SIGMA-ALDRICH, MO, USA). 
Then samples were washed three times with PBS and incubated with secondary antibody 
conjugated to Alexa Fluor at room temperature for 1 hr. Samples were counterstained 
with Hoechst 33258 (Polysciences, Inc., PA, USA) for 5 min and imaged using a confocal 
microscope (OLYMPUS FLUOVIEW FV1000, respectively; OLYMPUS, Tokyo, Japan). 
 
Statistical analysis 
For analysis of AMPK activity, specific activities of AMPK were compared using 
unpaired Student’s t-test. For the remaining analysis, one-way ANOVA followed by the 
Tukey-Kramer post hoc test for multiple comparisons was performed. P values < 0.05 
were considered to represent statistical significance (*p< 0.05, **p< 0.01 compared to 
control). Groups without the same letter represent significantly different (p< 0.05). 
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RESULTS 
 
Absorption of acetic acid by differentiated L6 myotube cells 
To assess the ability of L6 myotubes to absorb acetic acid, 0.5 mM acetic acid was 
added to cultured cells and the amount of acetic acid taken up by the cells was measured. 
Acetic acid was immediately taken up within 2 min of incubation (Fig 1). 
 
Fig 1. Uptake of acetic acid by L6 myotube cells.  
After treatment with acetic acid (0.5 mM), acetic acid content in the medium was determined at each 
indicated time point and the amount of uptake by the cells was calculated. Each value is shown as the 
mean ± SE (n=3-6). Reprinted and revised by PLOS ONE 11(16): e0158055, 2016. 
 
Acetic acid raises AMP concentration in differentiated L6 myotube cells 
 Following the absorption of acetic acid by cells, acetic acid is converted to acetyl-
CoA concomitantly with the formation of AMP, a well-known activator of AMPK, via the 
catalytic activity of acetyl-CoA synthetase in the cytosol. AMP concentration in cells 
incubated with 0.5 mM acetic acid was consistently higher than that in non-treated steady 
state control cells (0 min), and significantly increased in 2 min compared to the steady 
state concentration (Table 1). The AMP/ATP ratio during incubation with acetic acid was 
significantly increased in 2 min of the addition of acetic acid.  
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Table 1. Stimulation of the AMP/ATP ratio in L6 myotube cells by treatment with acetic 
acid.  
Adenine nucleotides (μmol/g of protein) in L6 cells treated with 0.5 mM acetic acid for the indicated 
times. Each value is shown as the mean ± SE (n=3-4). Results were analyzed with one-way ANOVA 
followed by the Tukey-Kramer post hoc test for multiple comparisons. Statistical differences are 
shown as *p＜0.05 compared to the 0 min time point. 
 
Acetic acid induces phosphorylation of AMPK and ACC in differentiated L6 cells 
To determine whether the treatment with acetic acid can induce phosphorylation of 
AMPK at Thr172 in L6 cells, the change of phosphorylated AMPK levels was analyzed. 
Phosphorylation of AMPK was significantly increased in acetic acid-treated cells 
compared to in non-treated control cells. Ten minutes after the addition of the indicated 
amount of acetic acid to the culture medium, phosphorylated AMPK increased in a dose-
dependent manner (Fig 2A). 
A time-course study revealed that incubation with 0.5 mM acetic acid increased the 
phosphorylation of AMPK after the addition of acetic acid (Fig 2B). Treatment with 
AICAR, an AMPK activator, also increased the phosphorylation of AMPK by about 2.2-
fold at 12 hr after the addition. Pre-treatment of cells with compound C and araA, potent 
AMPK inhibitors, suppressed the acetic acid induced phosphorylation of AMPK (Figs 2C 
and D). Phosphorylation of AMPK was also analyzed after treatment with other acid 
compounds such as 0.5 mM lactic acid and 0.5 mM citric acid. Both compounds did not 
enhance the phosphorylation of AMPK (Fig 2E). 
Time 
ATP ADP AMP Total 
AMP/ATP 
(µmol / g of protein) 
0 min 20.95 ± 3.65 5.53 ± 0.71 0.86 ± 0.07 27.35 ± 4.45 0.041 ± 0.007 
0.5 min 18.52 ± 2.83 6.48 ± 0.16 2.06 ± 0.51 27.06 ± 2.61 0.111 ± 0.051 
2 min 19.73 ± 1.91 6.81 ± 0.49 4.43 ± 0.47* 30.96 ± 1.17 0.224 ± 0.061* 
30 min 18.95 ± 1.01 8.66 ± 0.31* 3.38 ± 1.43 30.99 ± 0.57 0.179 ± 0.018 
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One downstream target of AMPK is phosphorylation of ACCβ at Ser79. 
Phosphorylated ACC was significantly increased at 10 min after treatment with 0.5 mM 
acetic acid (Fig 2F), and the addition of compound C and araA together with acetic acid 
led to suppression of this phosphorylation (Figs 2F and G). This increase in 
phosphorylation was also seen in the treatment with AICAR, and inhibited by addition of 
compound C. 
Moreover, we also conducted an evaluation of AMPK activity in L6 myotube cells using 
the SAMS peptide as a substrate of AMPK. AMPK activity was significantly increased 
in cells treated with acetic acid compared to non-treated control cells (Fig 2H). 
 
Acetic acid treatment increases mRNA and protein expression of myoglobin and 
GLUT4 in L6 myotube cells 
 Transcripts of myoglobin and GLUT4 were increased in cells treated with acetic acid. 
Time-course studies revealed that mRNA levels of myoglobin gene, Mb and GLUT4 gene, 
Slc2a4 were significantly higher than those of non-treated steady state control cells (Figs 
3A and B). Furthermore, pre-treatment with compound C or araA and acetic acid 
completely suppressed the increase in expression of Mb and Slc2a4 genes (Figs 3C-F). 
Expression of these proteins were also significantly increased and this stimulation was 
completely suppressed in the presence of compound C and araA (Figs 3G-J) 
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Fig 2. Acetic acid induces phosphorylation of AMPK and ACC in L6 myotube cells.  
L6 myotube cells were treated with 0, 0.05, 0.15, 0.3, and 0.5 mM acetic acid for 10 min (A). Cells 
were incubated with 0.5 mM acetic acid for the indicated time (B), 0.5 mM AICAR for 12 hr, and 10 
μM compound C for 30 min (C), 2 mM araA for 20 min (D), and 0.5 mM lactic acid or 0.5 mM citric 
acid for 10 min (E), and analyzed for the phosphorylation of AMPK. Cells were treated with 0.5 mM 
acetic acid for 10 min and 0.5 mM AICAR for 12 hr, and 10 μM compound C for 30 min (F) and 2 
mM araA for 20min (G), and analyzed for phosphorylation of ACC and ACCβ. After L6 myotube cells 
were treated with 0.5 mM acetic acid for 2 min, cell lysates were prepared. Then, AMPK was 
immunoprecipitated from cell extracts and AMPK activity was measured using the synthetic SAMS 
peptide as a substrate (50 μM and 150 μM) (H). Each bar represents the mean ± SE (n=3-4). Results 
were analyzed with one-way ANOVA followed by the Tukey-Kramer post hoc test for multiple 
comparisons (A-G), or analyzed by an unpaired Student’s t-test (H). Statistical differences are shown 
as *p< 0.05, **p< 0.01 compared to non-treated (A). Groups without the same letter are significantly 
different (p< 0.05) (B-G). Reprinted and revised by PLOS ONE 11(16): e0158055, 2016. 
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Fig 3. Effects of acetic acid on the expression of myoglobin and GLUT4 in L6 myotube cells.  
Total RNA was extracted from untreated L6 myotube cells or those treated with 0.5 mM acetic acid 
for the indicated time period (A; Mb, B; Slc2a4) or for 5 min after the addition of acetic acid (C; Mb, 
D; Slc2a4) or 0.5 mM AICAR for 12 hr, and10 μM compound C for 30 min or 2mM araA for 20min. 
Real-time PCR analysis was carried out for determination of Mb (A, C, E) and Slc2a4 (B, D, F) mRNA 
levels in L6 myotube cells. Myoglobin or GLUT4 proteins were analyzed by western blotting on the 
treatment of 0.5 mM acetic acid for 10 min, 0.5 mM AICAR for 12 hours, and 10 μM compound C 
for 30 min (G, H) or 2 mM araA for 20 min (I, J). Each bar represents the mean ± SE (n=3-6). Results 
were analyzed with one-way ANOVA followed by the Tukey-Kramer post hoc test for multiple 
comparisons. Groups without the same letter are significantly different (p< 0.05). Reprinted and 
revised by PLOS ONE 11(16): e0158055, 2016. 
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Acetic acid increases glucose and fatty acid uptake, and suppresses triglyceride 
accumulation in L6 myotube cells 
 To investigate whether the activation of AMPK by acetic acid stimulates uptake of 
glucose, glucose clearance was examined in cells treated with acetic acid. After insulin 
treatment, glucose uptake was approximately 3 times higher than that of non-treated 
controls. Similarly, acetic acid as well as AICAR treatment significantly increased 
glucose uptake (Fig 4A). Treatment with acetic acid tended to increase the utilization of 
fatty acid, but reduced their accumulation as triglyceride in the cells compared to non-
treated control or AICAR treatment (Figs 4B and C). 
 
Fig 4. Effects of acetic acid treatment on glucose, fatty acid uptake and triglyceride 
accumulation in L6 myotube cells.  
(A) Glucose uptake by L6 cells. Differentiated L6 myotube cells were treated with 0.5 mM acetic acid 
and 100 nM insulin for 24 and 48 hrs in the medium (50 μmol/2 ml). Each conditioned medium was 
collected and measured the concentration of glucose. Amount of glucose uptake was calculated by 
using the amount of glucose remaining in the medium. (B) Fatty acid uptake by L6 cells. (C) TG 
accumulation in L6 cells. Differentiated L6 myotube cells were incubated with the medium containing 
0.6 μmol palmitic acid (300 μmol/L) for 24 and 48 hrs in the presence or absence of 0.5 mM acetic 
acid or 0.5 mM AICAR. After the incubation, mediums and cells were collected separately and the 
concentration of NEFA in the mediums and the concentration of TG in the cells were determined. Each 
bar represents the mean ± SE (n=3-4). Results were analyzed with one-way ANOVA followed by the 
Tukey-Kramer post hoc test for multiple comparisons. Groups without the same letter are significantly 
different (p< 0.05). Reprinted and revised by PLOS ONE 11(16): e0158055, 2016. 
 
 
 40 
 
Acetic acid treatment increases mRNA and protein expression of MEF2A in L6 
myotube cells 
 MEF2A plays an important role in the regulation of gene expression of myoglobin 
and GLUT4 in skeletal muscle [26]. MEF2 proteins are transcription factors involved in 
the differentiation of skeletal muscle, and possess diverse cellular functions in skeletal 
muscles or neurons. We focused on MEF2A and hypothesized that the increase in mb and 
Slc2a4 gene expression by acetic acid treatment might be associated with the function of 
MEF2A, as well as with the activation of AMPK.   
Transcript levels of mef2a were significantly higher in cells treated with acetic acid 
than those of non-treated control (Fig 5A). Pre-treatment with compound C or araA 
completely suppressed the induction of mef2a mRNA by acetic acid (Figs 5B and C). 
Protein expression of MEF2A was also increased upon acetic acid treatment (Figs 5D and 
E), which was abolished by compound C and araA. 
  
 
 
 
 
 
Fig 5. Effect of acetic acid on the expression of MEF2A in L6 myotube cells.  
Total RNA was extracted from untreated L6 myotube cells or cells treated with 0.5 mM acetic acid for 
the indicated time period (A). L6 cells were treated with 0.5 mM acetic acid for 5 min, 0.5 mM AICAR 
for 12 hours, and pre-treated with 10 μM compound C for 30 min (B), and pre-treated with 2 mM araA 
for 20 min (C).  Real-time PCR analysis was carried out for the determination of mef2A mRNA level 
in L6 myotube cells. MEF2A protein was analyzed by western blotting in 10 min treatment of 0.5 mM 
acetic acid, 0.5 mM AICAR for 12 hours, and 10 μM compound C for 30 min (D) or 2 mM araA for 
20 min (E). Each bar represents the mean ± SE (n=3-6). Results were analyzed with one-way ANOVA 
followed by the Tukey-Kramer post hoc test for multiple comparisons. Groups without the same letter 
are significantly different (p< 0.05). Reprinted and revised by PLOS ONE 11(16): e0158055, 2016. 
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Acetic acid treatment increases mRNA and protein expression of PGC-1 in L6 
myotube cells 
PGC-1α is a transcriptional coactivator that mediates many biological processes 
related to energy metabolism. PGC-1α and MEF2 form a positive feedback loop [66]. 
Activation of AMPK has been implicated to be involved in the upregulation of ppargc1a 
expression [67]. Transcript levels of ppargc1a were significantly higher in cells treated 
with acetic acid than in non-treated control (Fig 6A). Pre-treatment with compound C or 
araA, and acetic acid completely suppressed the induction of ppargc1a mRNA (Figs 6B 
and C). Protein expression of PGC-1α was also increased upon treatment with acetic acid 
(Figs 6D and E).  
 
Fig 6. Effect of acetic acid on the expression of PGC-1α in L6 myotube cells.  
Total RNA was extracted from untreated L6 myotube cells or cells treated with 0.5 mM acetic acid for 
the indicated time period (A). L6 cells were treated with 0.5 mM acetic acid for 5 min, 0.5 mM AICAR 
for 12 hours, and pre-treated with 10 μM compound C for 30 min (B) or 2 mM araA for 20 min (C), 
and total RNA were isolated. Real-time PCR analysis was carried out for the determination of 
ppargc1a mRNA level in L6 myotube cells. PGC-1α protein level was analyzed by western blotting 
in 5 min treatment with 0.5 mM acetic acid, 0.5 mM AICAR for 12 hours, and 10 μM compound C 
for 30 min (D) or 2 mM araA for 20 min (E). Each bar represents the mean ± SE (n=3-6). Reprinted 
and revised by PLOS ONE 11(16): e0158055, 2016. 
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Acetic acid induces nuclear localization of MEF2A  
 The nuclear MEF2A protein level was measured by western blotting to see the 
nuclear localization of MEF2A. Nuclear MEF2A was significantly increased at 5 min 
(2.1-fold), 10 min (3.3-fold) and 30 min (2.3-fold) after treatment with acetic acid 
compared to non-treated control (Fig 7A). In contrast, there was no change in the 
cytosolic MEF2A levels (Fig 7B). However, nuclear localization of MEF2A was 
significantly reduced in the presence of compound C (Fig 7A). Furthermore, we analyzed 
L6 myotube cells by confocal immunofluorescence. Fig 7C is the typical image showing 
that MEF2A was localized in nucleus in L6 cells treated with acetic acid, while it was 
localized in the cytosol in the presence of compound C and in non-treated cells (Fig 7C). 
And the nuclear localization rate of MEF2A was significantly increased by the treatment 
of acetic acid (Fig 7D).  
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Fig 7. Effect of acetic acid treatment on nuclear MEF2A expression in L6 myotube cells. 
L6 myotube cells were treated with 0.5 mM acetic acid, and nuclear fraction (A) and cytosolic fraction 
(B) were separated. MEF2A level was examined by western blotting as described in materials and 
methods. L6 myotube cells were cultured on glass cover slips coated with poly-L-lysine and treated 
with 0.5 mM acetic acid in the presence or absence of 10 μM compound C (C). Then cells were fixed 
and nuclear DNA was stained by Hoechst 33258 (blue). Cells were immunostained for MEF2A (red) 
and myosin (green). Scale bar = 20 μm. The nucleus immunostained with anti-MEF2A antibody were 
counted (8 mm2 area, n=3) and the rate of nuclear localization of MEF2A was calculated (D). Each 
bar represents the mean ± SE (n=3-4).  
Reprinted and revised by PLOS ONE 11(16): e0158055, 2016. 
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DISCUSSION 
 
Skeletal muscle is one of the most important insulin-responsive organs in the body 
[29,30], and an accumulation of locally derived fat metabolites in skeletal muscle is an 
important factor contributing to insulin resistance [29]. It has been demonstrated that 
AMPK plays a key role in regulating fat oxidation and glucose metabolism via 
upregulation of mitochondrial proteins, GLUT4, and several metabolic enzymes in mice, 
rats, or human skeletal muscles [23–25,28,60–62]. Present data indicate that acetic acid 
functions as an activator of AMPK and might be able to suppress lipogenesis via 
enhancing lipid metabolism. When acetic acid is taken up into tissues, it is converted to 
acetyl-CoA with concomitant formation of AMP by the catalytic activity of acetyl-CoA 
synthetase [68–73]. Acetic acid is easily absorbed by L6 myotube cells, and increases the 
AMP/ATP ratio in the cells. An increase in AMP/ATP ratio stimulates the phosphorylation 
of AMPK. Phosphorylated AMPK increased in a dose-dependent manner with the 
concentration of acetic acid (Fig 2A), which was in the range of physiological blood 
concentration of acetic acid. Pre-treatment of cells with compound C inhibited 
phosphorylation of AMPK by acetic acid (Fig 2C). Moreover, other acids such as lactic 
acid or citric acid were unable to increase the phosphorylation of AMPK (Fig 2E). 
Activated AMPK leads to an inactivation of ACC via phosphorylation, a decrease in 
malonyl-CoA content, a subsequent increase in fatty acid oxidation, and a block in fatty 
acid synthesis. Phosphorylation of ACC significantly increased at 10 min of acetic acid 
treatment (Fig 2F) and it was inhibited by pre-treatment with compound C and araA (Figs 
2F and 2G). In our previous study, chronic intake of acetic acid induced gene expression 
of myoglobin and GLUT4 in skeletal muscle of rats, and the rats showed a higher rate of 
oxygen consumption and a smaller size of lipid droplets in white adipose tissue [63]. In 
this study, transcripts and protein levels of myoglobin and GLUT4 were increased in 
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acetic acid-treated L6 myotube cells. Pre-treatment of acetic acid treated cells with 
compound C and araA completely suppressed the increase of myoglobin and GLUT4 
gene and protein expression (Figs 3C, E, D-J), suggesting that acetic acid induces 
myoglobin and GLUT4 transcription through the AMPK-mediated signaling pathway in 
L6 myotube cells. Myoglobin is expressed in cardiac and skeletal myocytes, and it plays 
a role in the diffusion of oxygen and to maintain mitochondrial respiration [37]. The 
myoglobin gene is expressed depending on myofiber subtypes, and the expression is 
regulated by environmental stimuli such as chronic hypoxia and endurance exercise 
training [38–41]. GLUT4 is one of the glucose transport proteins and is responsible for 
insulin-mediated glucose uptake in muscle and adipose tissue. It was shown that glucose 
homeostasis depends on the level of GLUT4 expression [74–76].  
Transcription of myoglobin and GLUT4 genes is regulated by MEF2, which is a 
transcription factor involved in skeletal muscle differentiation [42–44,47,49,50,77]. The 
MEF2 family is comprised of four members, MEF2A, B, C and D [46,78], and belongs 
to the MCM1-agamous-deficiens-serum response factor (MADS) supergene family of 
DNA binding proteins [78–80]. MEF2B is a unique member of the MEF2 gene family 
[81] and its expression is restricted to myogenic lineages during early embryo 
development [82]. MEF2D is expressed in proliferating myoblasts prior to the onset of 
differentiation [46,83]. MEF2C is expressed late in the differentiation program, and 
MEF2A protein appears in cells entering the differentiation pathway and the expression 
is regulated at multiple levels during development and differentiation. The predominant 
MEF2 DNA-binding complex in muscle cells is composed of MEF2A homodimers [46]. 
There is a MEF2 binding site in GLUT4 promoters that contains the binding site of a 
MEF2A-MEF2D heterodimer. Reduced MEF2A expression accounts for the reduction in 
DNA binding activity and directly correlates with the decrease in GLUT4 gene expression 
[84]. MEF2A is a substrate for p38 mitogen-activated protein (MAP) kinase (MAPK), 
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and 312 and 319 within the transcription activation domain of MEF2A are phosphorylated 
by p38 [85]. Phosphorylated MEF2A enhances MEF2-dependent gene expression. 
MAPK-independent pathways such as the AMPK-associated pathway have also been 
implicated in the regulation of MEF2 [48]. Treatment of human skeletal muscle cells with 
AICAR, a pharmacological activator of AMPK, stimulated MEF2 DNA binding activity 
[48]. AICAR-mediated MEF2 DNA binding was independent of p38 MAPK activation, 
and it was completely inhibited by an AMPK inhibitor, compound C [48]. AICAR-
injected rats showed increased nuclear MEF2 DNA binding activity, and chronic AICAR 
treatment dramatically increased the expression of glucose transport protein GLUT4 in 
muscle [86]. In this study, we observed that MEF2A nuclear localization was increased 
upon treatment with acetic acid and it was inhibited by pre-treatment with compound C 
(Fig 7). Furthermore, transcripts of MEF2A and PGC-1α genes were significantly 
increased in cells treated with acetic acid (Figs 5A-C, 6A-C). PGC-1α plays a key role in 
the regulation of mitochondrial biogenesis and oxidative metabolism and its activity has 
been reported to be regulated by AMPK [87]. MEF2A and PGC-1α contain a MEF2A 
binding site in their promoter sequences [66,88] and their gene expression was 
coordinated with one another [66]. Those findings implicate that acetic acid induced 
expression of both MEF2A and PGC-1α as well as of myoglobin and GLUT4 genes might 
be caused by an increase in nuclear localization of MEF2A via the activation of AMPK. 
De Angelis et al. showed that transforming growth factor β (TGF-β) inhibited 
myogenesis and prevented the activation of the transcriptional complex related to MEF2A 
through localization of MEF2A in the cytoplasm [89]. Furthermore, activated AMPK 
inhibited TGF-β, Smad3 gene expression, and TGF-β-induced myofibroblast 
differentiation [90–92]. In this study, MEF2A, which contains a nuclear localization 
sequence at its C-terminus [46,93], was localized in the nucleus shortly after treatment 
with acetic acid and exported to the cytoplasm 30 min after treatment. Investigation of 
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the transport mechanism of MEF2A upon treatment with acetic acid is currently underway. 
mRNA and protein expression levels of MEF2A were significantly increased upon 
treatment with acetic acid in L6 myotube cells (Fig 5). In addition, pre-treatment of acetic 
acid-treated cells with compound C completely suppressed the increase in MEF2A 
mRNA and protein expression levels (Figs 5B and D). A ChIP assay revealed that the 
MEF2A promoter contains a MEF2A binding site and that MEF2A would associate with 
the site to control the MEF2A transcription [88]. These results implicate that increased 
expression of MEF2A by acetic acid might be caused by increased nuclear localized 
MEF2A via the activation of AMPK.  
Activation of AMPK is linked to lipid catabolism and improvement of insulin 
sensitivity [62]. Numerous AMPK activators have been described including adiponectin 
or berberine. Adiponectin, which is an adipocytokine preventing metabolic syndrome or 
atherosclerosis, activates AMPK in skeletal muscle and improves insulin sensitivity 
[67,94] Berberine, a food component, has an effect on AMPK activation, adipose tissues, 
and macrophages [95,96]. In this study, acetic acid activated AMPK, induced gene and 
protein expression of myoglobin and GLUT4, stimulated glucose incorporation, and 
suppressed lipid accumulation in L6 cells. Thus, acetic acid has the potential to prevent 
metabolic disorders through the activation of AMPK.  
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Diabetes is one of the most emergent health problem of the world in the 21st century. 
Diabetes continues to increase in most parts of the world. Furthermore, Asians, including 
Japanese, had the highest postprandial glycemia and lowest insulin sensitivity [97]. Thus, 
it is one of the most important issue to solve. Several studies reported that acetic acid has 
been such effects as a suppression of increased postprandial glycemia [98], protection 
against high-fat diet induced obesity and insulin resistance [99], appetite suppression 
[100] and activated AMPK in the liver and adipose tissue [101] etc. AMPK is a key 
regulator of nutrient metabolism and energy homeostasis [10,102]. AMPK functions as 
an energy sensor at the cellular, and when it is activated, it leads to an increase of fatty 
acid oxidation, glucose uptake independently with insulin, glycolysis, mitochondrial 
biogenesis, and decrease lipogenesis [62,102]. Therefore, increased AMPK activation is 
important to prevent and cure of obesity and type 2 diabetes. Actually, it is known that 
the mechanism of action of metformin, used drug for treatment of type 2 diabetes, is due 
to the activation of AMPK. 
In this study, chronic intake of acetic acid induced gene expression of myoglobin and 
GLUT4 in skeletal muscle of rats, and the rats showed a higher rate of oxygen 
consumption and a smaller size of lipid droplets in white adipose tissue. Transcripts and 
protein levels of myoglobin and GLUT4 were increased in acetic acid-treated rats and L6 
myotube cells. Pre-treatment of acetic acid treated cells with compound C and araA 
completely suppressed the increase of myoglobin and GLUT4 gene and protein 
expression, suggesting that acetic acid induces myoglobin and GLUT4 transcription 
through the AMPK-mediated signaling pathway. Treatment of acetic acid increased 
MEF2A and PGC-1α genes and proteins and it was appeared that those expressions were 
led by activation of AMPK. Those findings implicate that acetic acid induces expression 
of both MEF2A and PGC-1α as well as of myoglobin and GLUT4 genes and it could 
result, stimulations of lipid oxidation and glucose uptake. 
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Activation of AMPK is involved in improving lipid metabolism and insulin 
sensitivity. Thus, acetic acid may contribute to the prevention of metabolic disorders such 
as obesity and diabetes. It is useful to develop the easy way to take vinegar in the future 
study that will help for health promotion. 
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